SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025064
Filing Date
2021-05-06
Accepted
2021-05-06 16:38:51
Documents
86
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bbio-10q_20210331.htm   iXBRL 10-Q 3336864
2 EX-10.3 bbio-ex103_356.htm EX-10.3 684903
3 EX-10.4 bbio-ex104_127.htm EX-10.4 59776
4 EX-31.1 bbio-ex311_8.htm EX-31.1 22017
5 EX-31.2 bbio-ex312_7.htm EX-31.2 22095
6 EX-32.1 bbio-ex321_6.htm EX-32.1 11839
7 EX-32.2 bbio-ex322_10.htm EX-32.2 11542
  Complete submission text file 0001564590-21-025064.txt   14680321

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA bbio-20210331.xsd EX-101.SCH 97512
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bbio-20210331_cal.xml EX-101.CAL 77967
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bbio-20210331_def.xml EX-101.DEF 358268
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bbio-20210331_lab.xml EX-101.LAB 692365
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bbio-20210331_pre.xml EX-101.PRE 537494
13 EXTRACTED XBRL INSTANCE DOCUMENT bbio-10q_20210331_htm.xml XML 3074719
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 21898507
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences